Spyre Therapeutics, Inc. insider trading activity

Understanding Insider Activity at Spyre Therapeutics, Inc.

Welcome to our dedicated page for Spyre Therapeutics, Inc. (Nasdaq: SYRE) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by Spyre Therapeutics, Inc.'s key insiders, providing a unique window into the company's internal sentiments.

How to Use This Data:

Below, you can view insider transactions that were reported to the SEC within the last 365 days.

While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.

Scroll down to view the most recent insider transactions for Spyre Therapeutics, Inc., and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.

Track insider trades for SYRE
TickerTime & DateFilingLink
SYRE9:53:52 PM 11/8/2024
Albers Jeffrey W. sold 6700 shares of Spyre Therapeutics, Inc. (SYRE) for ~$246292
Filing
SYRE8:41:05 PM 10/28/2024
Albers Jeffrey W. sold 300 shares of Spyre Therapeutics, Inc. (SYRE) for ~$10929
Filing
SYRE8:04:14 PM 9/5/2024
Burrows Scott L(Chief Financial Officer) sold 18531 shares of Spyre Therapeutics, Inc. (SYRE) for ~$522018
Filing